US Edition
News from pharmtech.com
We’ve assigned a media bias rating of Center to pharmtech.com. You can read more about our methodology here.
If you want to know if pharmtech.com is credible or reliable, look no further. We rank pharmtech.com as High factuality. Find out more about our methodology here.
Media Bias Ratings
Average Bias Rating:
Center
Center
byAd Fontes MediaDo you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top pharmtech.com News
FinanceGastonia approved new incentives for Project Nexus, a manufacturing proposal that could bring 701 jobs and a $268M investment to Trinity Capital’s Delta Industrial Park. The building has been vacant since 2023. A decision is expected by June.See the Story
Company eyes vacant Gastonia building for 701-job, $268M project
67% Center coverage: 3 sources
Donald Trump · United StatesThe White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.See the Story
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
67% Center coverage: 3 sources
Innovation · United StatesThe company said the investment is in response not only to customer demand and a belief in the value of US-based innovation, but also because of the trend toward US onshoring brought about by new tariff policies.See the Story
Piramal Pharma to Invest $90 Million at Kentucky & Michigan Sites
Coverage: 2 sources
